首页> 外文期刊>Radiation Science and Technology >Entrance Surface Air Kerma for Skull, Pelvis and Abdomen X-ray Examinations in Some Diagnostic Radiology Facilities in Akwa Ibom State, Nigeria
【24h】

Entrance Surface Air Kerma for Skull, Pelvis and Abdomen X-ray Examinations in Some Diagnostic Radiology Facilities in Akwa Ibom State, Nigeria

机译:尼日利亚阿夸伊博姆州某些诊断放射设施中用于头骨,骨盆和腹部X射线检查的入口地面空气Kerma

获取原文
       

摘要

This study estimates entrance surface air kerma(ESAK) for Skull, Pelvis and Abdomen X-ray examinations in selected diagnostic radiology facilities in AkwaIbom State, Nigeria.Eight (8) facilities in eight hospitals were investigated.Six hundred and thirty threeadult patients who presented for these examinations under study were investigated. Gender distribution shows that 263 (41.5%) were males while 370 (58.5%) were females.For skull examination the calculated ESAK range was between 0.07 to 0.57 mGy for males and females patient respectively, ESAK range of 0.03 to 0.28 mGy for males and females respectively in pelvis examination while in abdominal examination the ESAK for male varied between 0.05 to 1.16 mGy and 0.04 to 0.73 mGy for female patients. Mean organ doses indicate that the eyes absorbed a dose of 10.19 mGy,the gonads absorbed the highest dose, uterus and prostate gland absorbed 0.43 mGy and 0.33 mGy respectively. Liver absorbed 1.51 mGy, ovaries, 2.62 mGy, testes, 0.08 mGy. The meaneffective dose (ED) range of 0.02 - 0.11 mSv in skull examination while ED for pelvis and abdomen examinations ranges are (0.07 - 0.52) mSv and (0.78 - 5.37) mSv respectively. The evaluated cancer incidence and mortality risks were very low and minimal.
机译:这项研究估计了尼日利亚阿克沃博姆州选定的放射诊断设施对头骨,骨盆和腹部X射线检查的入口表面空气比释动能(ESAK),对八家医院的八(8)个设施进行了调查。对于这些正在研究的考试进行了调查。性别分布显示,男性263(41.5%),女性370(58.5%)。对于头骨检查,男性和女性患者的ESAK范围分别在0.07至0.57 mGy之间,男性和女性患者的ESAK范围在0.03至0.28 mGy之间。女性分别在骨盆检查和腹部检查中,男性的ESAK在0.05至1.16 mGy和女性患者的0.04至0.73 mGy之间变化。平均器官剂量表示眼睛吸收的剂量为10.19 mGy,性腺吸收的剂量最大,子宫和前列腺的吸收分别为0.43 mGy和0.33 mGy。肝脏吸收了1.51 mGy,卵巢吸收了2.62 mGy,睾丸吸收了0.08 mGy。颅骨检查的平均有效剂量(ED)范围为0.02-0.11 mSv,而骨盆和腹部检查的平均有效剂量范围分别为(0.07-0.52)mSv和(0.78-5.37)mSv。评估的癌症发病率和死亡率风险非常低且很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号